Article Details
Retrieved on: 2024-01-31 19:26:23
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Developed by Pfizer, abrocitinib has received marketing authorisation from the Central Drugs Standard Control Organization (CDSCO) in India and is ...
Article found on: health.economictimes.indiatimes.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here